Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Colorectal Neoplasms 42Colonic Neoplasms 14Rectal Neoplasms 13Neoplasms 12Neoplasm Metastasis 12Head and Neck Neoplasms 6Esophageal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Carcinoma, Squamous Cell 4Breast Neoplasms 4Recurrence 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Adenocarcinoma Of Esophagus 3Triple Negative Breast Neoplasms 2Gastrointestinal Neoplasms 2Cholangiocarcinoma 2Carcinoma 2Biliary Tract Neoplasms 2Urinary Bladder Neoplasms 1Solid Tumors 1Ovarian Neoplasms 1Inflammatory Breast Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Exanthema 1

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × Panitumumab × Clear all
NCT02593175 2025-11-06

Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC

M.D. Anderson Cancer Center

Phase 2 Completed
43 enrolled 8 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01036087 2023-03-30

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
47 enrolled 13 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01009983 2018-07-06

Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer

Wake Forest University Health Sciences

Phase 2 Terminated
14 enrolled 11 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00894504 2015-05-15

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

SCRI Development Innovations, LLC

Phase 2 Completed
71 enrolled 7 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡